Beyond its medical applications, hydroxychloroquine has been involved in geopolitical conversations, especially when countries debated over access to
hydroxychloroquine and rheumatoid arthritis. This scenario brought to light the complexities of international pharmaceutical supply chains and the strategic importance of drug manufacturing capabilities during health crises.
